Hesira Med Receives Health Canada Approval for OSSIX™ GRAFT

OTTAWA, Oct. 14, 2016 /CNW/ - Hesira Med Inc. is pleased to announce that OSSIX™ GRAFT an allograft bone particulate is now commercially available for use in Canada.  It is part of the OSSIX® line of dental regenerative products which is known to provide proven results to facilitate quality bone. OSSIX™ GRAFT is applicable for socket preservation, ridge augmentation and regeneration of defects. Allowash® technology is used to retain the structural integrity of the bone. It is osteoinductive and supports fibroblast penetration, as well as tissue remodeling.

"We are passionate about importing products into Canada that have previously not been available. We believe that Canadian clinicians deserve best-in-class dental regenerative materials in order to achieve ideal treatment outcomes for patients."  - Chris Carriere, Managing Director.

About Hesira Med Inc.

Hesira Med is a Canadian owned and operated medical device distribution company. HesiraMed.com

Twitter: @Hesira_Med 
LinkedIn: Hesira Med Inc 
Facebook: Hesira Med


SOURCE Hesira Med Inc

Image with caption: "Logo: Hesira Med (CNW Group/Hesira Med Inc)". Image available at: https://photos.newswire.ca/images/download/20161014_C2666_PHOTO_EN_795685.jpg

For further information: Chris Carriere, info@hesiramed.com, 1-844-HESIRA-1

(514) 436-0735

Organization Profile

Hesira Med Inc

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890